GLP-1 Near Me in Chicago — Semaglutide $99/Mo, Tirzepatide $125/Mo | Trimi
Stop searching for GLP-1 clinics near you in Chicago. Trimi delivers compounded semaglutide and tirzepatide directly to your Chicago address in 2–3 business days — no clinic visits, no insurance required.
More on GLP-1 by Location
GLP-1 Weight Loss Treatment Available in Chicago
If you are searching for GLP-1 medication near you in Chicago, you have likely discovered that local weight loss clinics charge $300–800 per month and brand-name options like Wegovy and Zepbound cost $1,000–$1,400 without insurance. For many Chicago residents, these prices put effective weight loss treatment out of reach.
Trimi eliminates the need to find a GLP-1 clinic near you in Chicago. Through telehealth, you can access compounded semaglutide for $99/month or compounded tirzepatide for $125/month — delivered directly to any Chicago address. No clinic visit, no insurance, no prior authorization required.
Chicago GLP-1 Access Snapshot
Population: ~2.7 million city / ~9.5 million metro. Local clinic cost: $300–800/mo. Brand Wegovy/Zepbound: $1,000–$1,400/mo. Trimi telehealth: $99/mo semaglutide, $125/mo tirzepatide. Ships to any Chicago address.
Learn more about how telehealth prescribing works. You can also explore Ozempic vs. Wegovy or read our GLP-1 beginner guide.
Chicago GLP-1 Pricing: Trimi vs Local Providers & Pharmacies
| Option | Monthly Cost | In-Person Visit | Insurance Required |
|---|---|---|---|
| Chicago Weight Loss Clinic (avg) | $300–$800 | Yes | Sometimes |
| Chicago Pharmacy (brand Wegovy/Zepbound) | $1,000–$1,400 | Yes | Recommended |
| Trimi Telehealth (compounded) | $99/mo (sema) / $125/mo (tirz) | No | No |
Not sure which GLP-1 medication is right for you? Read our semaglutide vs. tirzepatide comparison.
How It Works: 3 Steps to Get GLP-1 Medication in Chicago
Step 1: Online Health Intake
Complete a health questionnaire covering your medical history, medications, BMI, and weight loss goals — from anywhere in Chicago.
Step 2: Provider Review & Prescription
A licensed Illinois provider evaluates your submission, confirms GLP-1 candidacy, and prescribes either semaglutide or tirzepatide based on your health profile.
Step 3: Delivered to Your Chicago Door
Temperature-controlled packaging arrives at your Chicago address within 3–5 business days. Monthly refills ship automatically.
Check our GLP-1 candidacy guide to see if you qualify for treatment.
GLP-1 Medications Available for Chicago Residents
Compounded Semaglutide
$99/month
- Same active ingredient as Wegovy
- GLP-1 receptor agonist
- ~15% average weight loss at 68 weeks
- No insurance required
Compounded Tirzepatide
$125/month
- Same active ingredient as Mounjaro/Zepbound
- Dual GLP-1/GIP receptor agonist
- ~22% average weight loss at 72 weeks
- No insurance required
Learn about compounded medication safety, read our first month guide, and see the GLP-1 weight loss timeline.
Why Chicago Residents Choose Trimi Over Local GLP-1 Clinics
Traditional weight loss clinics in Chicago require in-person visits, often have long wait times, and charge $300–800 per month. Trimi's telehealth model eliminates these barriers. Whether you're in Wicker Park, Evanston, or Oak Park or anywhere in the greater Chicago metro, your GLP-1 medication ships directly to your door for a flat monthly rate.
Explore our guide to managing GLP-1 side effects, learn about the telehealth process, or check out diet tips while on GLP-1 medications.
Ready to Start GLP-1 Treatment in Chicago?
Stop searching for GLP-1 clinics near you. Get compounded semaglutide ($99/mo) or tirzepatide ($125/mo) delivered to any Chicago address.
Get Started TodayFrequently Asked Questions: GLP-1 Near Me in Chicago
Where can I get GLP-1 medication near me in Chicago?
Trimi delivers GLP-1 medications directly to your Chicago address via telehealth. There is no need to search for a clinic near you — complete an online health intake, get evaluated by a licensed provider, and receive compounded semaglutide ($99/mo) or tirzepatide ($125/mo) shipped to your door.
How much do GLP-1 medications cost in Chicago?
Local Chicago weight loss clinics typically charge $300–800 per month for GLP-1 programs. Brand-name Wegovy or Zepbound cost $1,000–$1,400/month without insurance. Trimi offers compounded semaglutide for $99/month and tirzepatide for $125/month — shipped directly to your Chicago address.
Do I need a prescription for GLP-1 medication in Chicago?
Yes, GLP-1 medications like semaglutide and tirzepatide require a prescription from a licensed healthcare provider. Trimi's telehealth platform connects you with a licensed Illinois provider who evaluates your health history and prescribes the appropriate medication — all online.
How fast is GLP-1 shipping to Chicago?
Most Chicago residents receive their GLP-1 medication within 3–5 business days after prescription approval. Medication ships directly to your address — whether you're in Wicker Park, Evanston, or Oak Park.
What is the difference between semaglutide and tirzepatide?
Semaglutide (the active ingredient in Wegovy) targets GLP-1 receptors and produces approximately 15% body weight loss at 68 weeks. Tirzepatide (Mounjaro/Zepbound) targets both GLP-1 and GIP receptors, producing approximately 22% weight loss at 72 weeks. Trimi offers both options for Chicago residents.
Is telehealth prescribing for GLP-1 medications legal in Illinois?
Yes. Illinois law permits licensed providers to conduct telehealth evaluations and prescribe medications including GLP-1 agonists. Trimi connects Chicago residents with licensed providers who manage evaluation, prescribing, and ongoing care entirely online.
Can I switch between semaglutide and tirzepatide with Trimi in Chicago?
Yes. If you start with one medication and want to explore the other, your Trimi provider can evaluate whether switching is appropriate for your health profile. Many Chicago patients start with semaglutide ($99/mo) and later transition to tirzepatide ($125/mo) for enhanced results.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Semaglutide and tirzepatide are prescription medications requiring evaluation by a licensed healthcare provider. Individual results vary. Common side effects include nausea, vomiting, diarrhea, and constipation. Not appropriate for individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- Cook County Public Health Department. Community Health Assessment 2023.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).